Celgene (CELG) volatility decreases after $2.9 billion PHRM purchase
Tweet Send to a Friend
Celgene (Nasdaq: CELG) : CELG agreed to acquire PHRM, a manufacturer of blood-cancer treatments, for $2.9 billion in cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
